Pre-order Enquiry
Request Free Sample
Global Neuromodulation Devices and Implantable Infusion Pumps Market Research Report 2021
SKU ID : QYR-17254052 | Publishing Date : 25-Jan-2021 | No. of pages : 99
Detailed TOC of Global Neuromodulation Devices and Implantable Infusion Pumps Market Research Report 2021
1 Neuromodulation Devices and Implantable Infusion Pumps Market Overview1.1 Product Overview and Scope of Neuromodulation Devices and Implantable Infusion Pumps
1.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Spinal Cord Stimulation
1.2.3 Deep Brain Stimulation
1.2.4 Sacral Nerve Stimulation
1.2.5 Vagal Nerve Stimulation
1.2.6 Gastric Stimulation
1.2.7 Transcranial Magnetic Stimulation
1.2.8 Transcutaneous Electrical Stimulation
1.2.9 Other
1.3 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
1.3.1 Neuromodulation Devices and Implantable Infusion Pumps Sales Comparison by Application: (2021-2027)
1.3.2 Parkinson's Disease
1.3.3 Epilepsy
1.3.4 Pain
1.3.5 Other
1.4 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Estimates and Forecasts
1.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue 2016-2027
1.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales 2016-2027
1.4.3 Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region: 2016 Versus 2021 Versus 2027
2 Neuromodulation Devices and Implantable Infusion Pumps Market Competition by Manufacturers
2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturers (2016-2021)
2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Sites, Area Served, Product Type
2.5 Neuromodulation Devices and Implantable Infusion Pumps Market Competitive Situation and Trends
2.5.1 Neuromodulation Devices and Implantable Infusion Pumps Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Neuromodulation Devices and Implantable Infusion Pumps Players Market Share by Revenue
2.5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neuromodulation Devices and Implantable Infusion Pumps Retrospective Market Scenario by Region
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.3.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
3.3.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.4.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
3.4.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Region
3.5.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
3.5.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.6.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
3.6.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.7.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
3.7.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Neuromodulation Devices and Implantable Infusion Pumps Historic Market Analysis by Type
4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2021)
4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2016-2021)
4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2016-2021)
5 Global Neuromodulation Devices and Implantable Infusion Pumps Historic Market Analysis by Application
5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2021)
5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2016-2021)
5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Medtronic Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Boston Scientific Corporation Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Abbott Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Synapse Biomedical
6.4.1 Synapse Biomedical Corporation Information
6.4.2 Synapse Biomedical Description and Business Overview
6.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Synapse Biomedical Product Portfolio
6.4.5 Synapse Biomedical Recent Developments/Updates
6.5 Nevro Corporation
6.5.1 Nevro Corporation Corporation Information
6.5.2 Nevro Corporation Description and Business Overview
6.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Nevro Corporation Product Portfolio
6.5.5 Nevro Corporation Recent Developments/Updates
6.6 Neuropace
6.6.1 Neuropace Corporation Information
6.6.2 Neuropace Description and Business Overview
6.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Neuropace Product Portfolio
6.6.5 Neuropace Recent Developments/Updates
6.7 Cyberonics
6.6.1 Cyberonics Corporation Information
6.6.2 Cyberonics Description and Business Overview
6.6.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cyberonics Product Portfolio
6.7.5 Cyberonics Recent Developments/Updates
6.8 Autonomic Technologies
6.8.1 Autonomic Technologies Corporation Information
6.8.2 Autonomic Technologies Description and Business Overview
6.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Autonomic Technologies Product Portfolio
6.8.5 Autonomic Technologies Recent Developments/Updates
6.9 Avery Biomedical
6.9.1 Avery Biomedical Corporation Information
6.9.2 Avery Biomedical Description and Business Overview
6.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Avery Biomedical Product Portfolio
6.9.5 Avery Biomedical Recent Developments/Updates
6.10 Greatbatch Medical
6.10.1 Greatbatch Medical Corporation Information
6.10.2 Greatbatch Medical Description and Business Overview
6.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Greatbatch Medical Product Portfolio
6.10.5 Greatbatch Medical Recent Developments/Updates
7 Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Cost Analysis
7.1 Neuromodulation Devices and Implantable Infusion Pumps Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
7.4 Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors List
8.3 Neuromodulation Devices and Implantable Infusion Pumps Customers
9 Neuromodulation Devices and Implantable Infusion Pumps Market Dynamics
9.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Trends
9.2 Neuromodulation Devices and Implantable Infusion Pumps Growth Drivers
9.3 Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
9.4 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
10 Global Market Forecast
10.1 Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Neuromodulation Devices and Implantable Infusion Pumps by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Neuromodulation Devices and Implantable Infusion Pumps by Type (2022-2027)
10.2 Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Neuromodulation Devices and Implantable Infusion Pumps by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Neuromodulation Devices and Implantable Infusion Pumps by Application (2022-2027)
10.3 Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Neuromodulation Devices and Implantable Infusion Pumps by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Neuromodulation Devices and Implantable Infusion Pumps by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Neuromodulation Devices and Implantable Infusion Pumps Market Research Report 2021
List of TablesTable 1. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Covered in This Study
Table 5. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Manufacturers (2016-2021)
Table 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Neuromodulation Devices and Implantable Infusion Pumps Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Sites and Area Served
Table 11. Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Type
Table 12. Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromodulation Devices and Implantable Infusion Pumps as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2016-2021) & (K Units)
Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2016-2021)
Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2021) & (K Units)
Table 19. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2016-2021)
Table 20. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2016-2021)
Table 22. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2021) & (K Units)
Table 23. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2016-2021)
Table 24. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2016-2021)
Table 30. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2016-2021)
Table 32. Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2016-2021)
Table 38. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Type (2016-2021)
Table 39. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2021)
Table 40. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (Million US$) by Type (2016-2021)
Table 41. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Type (2016-2021)
Table 42. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Type (2016-2021)
Table 43. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Application (2016-2021)
Table 44. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2021)
Table 45. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (Million US$) by Application (2016-2021)
Table 46. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Application (2016-2021)
Table 47. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Application (2016-2021)
Table 48. Medtronic Corporation Information
Table 49. Medtronic Description and Business Overview
Table 50. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product
Table 52. Medtronic Recent Developments/Updates
Table 53. Boston Scientific Corporation Corporation Information
Table 54. Boston Scientific Corporation Description and Business Overview
Table 55. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product
Table 57. Boston Scientific Corporation Recent Developments/Updates
Table 58. Abbott Corporation Information
Table 59. Abbott Description and Business Overview
Table 60. Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Abbott Neuromodulation Devices and Implantable Infusion Pumps Product
Table 62. Abbott Recent Developments/Updates
Table 63. Synapse Biomedical Corporation Information
Table 64. Synapse Biomedical Description and Business Overview
Table 65. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 67. Synapse Biomedical Recent Developments/Updates
Table 68. Nevro Corporation Corporation Information
Table 69. Nevro Corporation Description and Business Overview
Table 70. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product
Table 72. Nevro Corporation Recent Developments/Updates
Table 73. Neuropace Corporation Information
Table 74. Neuropace Description and Business Overview
Table 75. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product
Table 77. Neuropace Recent Developments/Updates
Table 78. Cyberonics Corporation Information
Table 79. Cyberonics Description and Business Overview
Table 80. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product
Table 82. Cyberonics Recent Developments/Updates
Table 83. Autonomic Technologies Corporation Information
Table 84. Autonomic Technologies Description and Business Overview
Table 85. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product
Table 87. Autonomic Technologies Recent Developments/Updates
Table 88. Avery Biomedical Corporation Information
Table 89. Avery Biomedical Description and Business Overview
Table 90. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 92. Avery Biomedical Recent Developments/Updates
Table 93. Greatbatch Medical Corporation Information
Table 94. Greatbatch Medical Description and Business Overview
Table 95. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 97. Greatbatch Medical Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Neuromodulation Devices and Implantable Infusion Pumps Distributors List
Table 101. Neuromodulation Devices and Implantable Infusion Pumps Customers List
Table 102. Neuromodulation Devices and Implantable Infusion Pumps Market Trends
Table 103. Neuromodulation Devices and Implantable Infusion Pumps Growth Drivers
Table 104. Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
Table 105. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2022-2027) & (K Units)
Table 106. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2022-2027) & (K Units)
Table 110. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2022-2027) & (K Units)
Table 114. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Neuromodulation Devices and Implantable Infusion Pumps
Figure 2. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Type in 2020 & 2027
Figure 3. Spinal Cord Stimulation Product Picture
Figure 4. Deep Brain Stimulation Product Picture
Figure 5. Sacral Nerve Stimulation Product Picture
Figure 6. Vagal Nerve Stimulation Product Picture
Figure 7. Gastric Stimulation Product Picture
Figure 8. Transcranial Magnetic Stimulation Product Picture
Figure 9. Transcutaneous Electrical Stimulation Product Picture
Figure 10. Other Product Picture
Figure 11. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Application in 2020 & 2027
Figure 12. Parkinson's Disease
Figure 13. Epilepsy
Figure 14. Pain
Figure 15. Other
Figure 16. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size 2016-2027 (US$ Million)
Figure 18. Global Neuromodulation Devices and Implantable Infusion Pumps Sales 2016-2027 (K Units)
Figure 19. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 20. Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Manufacturers in 2020
Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Manufacturers in 2020
Figure 22. The Global 5 and 10 Largest Neuromodulation Devices and Implantable Infusion Pumps Players: Market Share by Revenue in 2020
Figure 23. Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2016-2021)
Figure 25. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region in 2020
Figure 26. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2016-2021)
Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region in 2020
Figure 28. U.S. Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Canada Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Germany Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. France Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. U.K. Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Italy Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Russia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. South Korea Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. India Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Australia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Taiwan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Indonesia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Thailand Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Malaysia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Philippines Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Vietnam Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Mexico Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Brazil Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Argentina Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Turkey Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. U.A.E Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. Sales Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Type (2016-2021)
Figure 53. Sales Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Application (2016-2021)
Figure 54. Sales Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Application in 2020
Figure 55. Revenue Share of Neuromodulation Devices and Implantable Infusion Pumps by Application (2016-2021)
Figure 56. Revenue Share of Neuromodulation Devices and Implantable Infusion Pumps by Application in 2020
Figure 57. Manufacturing Cost Structure of Neuromodulation Devices and Implantable Infusion Pumps
Figure 58. Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
Figure 59. Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Keyplayers in Global Neuromodulation Devices and Implantable Infusion Pumps Market Research Report 2021
MedtronicBoston Scientific Corporation
Abbott
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
Request Sample
Request Discount
